Nuvectis Pharma, Inc. (NVCT) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$8.72
-0.34%
Mkt Cap $240.54M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 11, 2026 | — | — | — | -$0.26 | -$0.31 | -19.23% | — | — |
| Q4 2025 Nov 4, 2025 | — | — | — | -$0.24 | -$0.44 | -83.33% | — | — |
| Q3 2025 Aug 5, 2025 | — | — | — | -$0.25 | -$0.30 | -20.00% | — | — |
| Q2 2025 May 6, 2025 | — | — | — | -$0.30 | -$0.27 | +10.00% | — | — |
| Q1 2025 Feb 25, 2025 | — | — | — | -$0.28 | -$0.36 | -28.57% | — | — |
| Q4 2024 Nov 5, 2024 | — | — | — | -$0.26 | -$0.24 | +7.69% | — | — |
| Q3 2024 Aug 6, 2024 | — | — | — | -$0.26 | -$0.26 | +0.00% | — | — |
| Q2 2024 May 7, 2024 | — | — | — | -$0.40 | -$0.25 | +37.50% | — | — |
| Q1 2024 Mar 5, 2024 | — | -$4.10M | — | -$0.40 | -$0.41 | -2.50% | — | — |
| Q4 2023 Nov 8, 2023 | — | — | — | -$0.38 | -$0.37 | +2.63% | — | — |
| Q3 2023 Aug 9, 2023 | — | — | — | -$0.34 | -$0.38 | -11.76% | — | — |
| Q2 2023 May 10, 2023 | — | $4.10M | — | -$0.44 | -$0.27 | +38.64% | — | — |
| Q1 2023 Mar 7, 2023 | — | $149.00K | — | -$0.38 | -$0.48 | -26.32% | — | — |
| Q4 2022 Nov 8, 2022 | — | — | — | -$0.27 | -$0.42 | -55.56% | — | — |
| Q3 2022 Aug 5, 2022 | — | -$140 | — | -$0.24 | -$0.28 | -16.67% | — | — |
| Q2 2022 May 10, 2022 | — | — | — | -$0.23 | -$0.32 | -39.13% | — | — |
| Q1 2022 Feb 7, 2022 | — | $4.00K | — | -$0.85 | -$0.18 | +79.08% | — | — |
| Q1 2022 Jan 14, 2022 | — | — | — | — | -$0.40 | — | — | — |
| Q2 2021 Jun 30, 2021 | — | — | — | — | -$0.47 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | — | — | — | -$0.00 | — | — | — |